Name: Data breakdown for study of Pfizer COVID-19 vaccine & children ages 5-11
Uploaded: 2021-10-28T00:03:20+00:00
Duration: 1 min 34 s
Description: As the decision process continues for the Pfizer COVID-19 vaccine for children ages 5-11, we're breaking down some of the study data from an FDA document.

2 years ago

As the decision process continues for the Pfizer COVID-19 vaccine for children ages 5-11, we're breaking down some of the study data from an FDA document.

Loading 2 comments...

Data breakdown for study of Pfizer COVID-19 vaccine & children ages 5-11

KMGH

360: FDA reviewing Pfizer's vaccine for ages 5-11

WPTV

COVID-19 vaccine safe for children ages 5-11, Pfizer says

The Post Millennial Live

CNN: Pfizer is seeking FDA approval of COVID-19 vaccine for children aged 5 to 11

Reuters

Pfizer COVID vaccine safe for younger kids -data

Reuters

Large study to test COVID vaccine in kids -Pfizer

JTN2020

Pfizer and BioNTech seek FDA approval for Covid vaccines for kids 4 and under

One America News Network

FDA committee to review Pfizer vaccine for children

Reuters

Pfizer seeks approval for COVID vaccine for kids

NarcityCanada

Health Canada Has Approved The Pfizer COVID-19 Vaccine For Canadians Aged 12 & Up

V.G PARALLEL SOCIETY

Pathologist: how the FDA Pfizer vaccine trial for 6 months to 4-year-old children was conducted.

Comments